{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:55:19Z","timestamp":1792788919361,"version":"4.5.0"},"reference-count":33,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82370342"],"award-info":[{"award-number":["82370342"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Top Talent Support Program for young and middle-aged people of Wuxi Health Committee","award":["BJ2023005"],"award-info":[{"award-number":["BJ2023005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Atrial fibrillation (AF) is one of the most prevalent arrhythmias following a myocardial infarction (MI), yet the pathogenesis associated with post-MI AF remains poorly understood. Enhancer of zeste homolog 2 (EZH2), an enzyme that regulates histone modifications, has been implicated in various cardiovascular diseases; however, the role of EZH2 in the development of post-MI AF also remains unclear. Methods: MI was induced in mice by ligation of the left anterior descending coronary artery (LAD), followed by intraperitoneal administration of GSK126 or vehicle control (polyethylene glycol 300 and saline). Results: MI significantly increased the incidence and duration of AF, while electrical mapping revealed decreased conduction velocity. These changes were accompanied by increased atrial fibrosis, which was associated with upregulation of EZH2 and trimethylated histone H3 at lysine 27 (H3K27me3). In GSK126-treated mice, the incidence of AF was reduced, along with a significant decrease in H3K27me3 expression and atrial fibrosis. Conclusion: Upregulation of EZH2 is associated with post-MI AF. Pharmacological inhibition of EZH2 using GSK126 attenuates atrial fibrosis and reduces the incidence of AF. These findings suggest that EZH2 may represent a potential therapeutic candidate for post-MI AF, although further validation is required.<\/jats:p>","DOI":"10.31083\/rcm51343","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:57:11Z","timestamp":1790693831000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhancer of Zeste Homolog 2 Inhibition Attenuates Atrial Fibrillation Post-Myocardial Infarction Through Reduced Atrial Fibrosis"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8068-1473","authenticated-orcid":true,"given":"Tian-Peng","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3273-5513","authenticated-orcid":true,"given":"Wen-Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1201-0958","authenticated-orcid":true,"given":"Xiao-Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9560-4971","authenticated-orcid":true,"given":"Huan-Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3193-1099","authenticated-orcid":true,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2260-5476","authenticated-orcid":true,"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-3594","authenticated-orcid":true,"given":"Xiao-Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-5048","authenticated-orcid":true,"given":"Ru-Xing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0317-5589","authenticated-orcid":true,"given":"Ling-Ling","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Wuxi People\u2019s Hospital Affiliated to Nanjing Medical University, 214023 Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, et al. Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction. Journal of the American Heart Association. 2021; 10: e021417.","DOI":"10.1161\/JAHA.121.021417"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Batra G, Svennblad B, Held C, Jernberg T, Johanson P, Wallentin L, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016; 102: 926\u2013933.","DOI":"10.1136\/heartjnl-2015-308678"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011; 123: 1587\u20131593.","DOI":"10.1161\/CIRCULATIONAHA.110.986661"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128: 693\u2013705.","DOI":"10.1016\/j.cell.2007.02.005"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Katanasaka Y, Yabe H, Murata N, Sobukawa M, Sugiyama Y, Sato H, et al. Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice. Nature Communications. 2024; 15: 2472.","DOI":"10.1038\/s41467-024-46711-z"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Xu J, Wang J, Long F, Zhong W, Su H, Su Z, et al. Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction. Cell & Bioscience. 2022; 12: 134.","DOI":"10.1186\/s13578-022-00877-5"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Song S, Zhang R, Mo B, Chen L, Liu L, Yu Y, et al. EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation. Journal of Molecular and Cellular Cardiology. 2019; 135: 119\u2013133.","DOI":"10.1016\/j.yjmcc.2019.08.003"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circulation Research. 2010; 107: 1445\u20131453.","DOI":"10.1161\/CIRCRESAHA.110.223925"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Liu HH, Yang F, Zhang L, Zhang XL, Zhao N, Zhang ZY, et al. Decreased PLK2 promotes atrial fibrillation in diabetic mice through Nrf2\/HO-1 pathway. Acta Diabetologica. 2025; 62: 1479\u20131492.","DOI":"10.1007\/s00592-025-02480-9"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Marion-Knudsen R, Lindberg LA, Jespersen T, Saljic A. Quantitative histologic assessment of atrial fibrillation-associated fibrosis in animal models: A systematic review. Heart Rhythm. 2026; 23: 473\u2013484.","DOI":"10.1016\/j.hrthm.2025.03.1880"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Meyer RE, Fish RE. A review of tribromoethanol anesthesia for production of genetically engineered mice and rats. Lab Animal. 2005; 34: 47\u201352.","DOI":"10.1038\/laban1105-47"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Frederiksen TC, Dahm CC, Preis SR, Lin H, Trinquart L, Benjamin EJ, et al. The bidirectional association between atrial fibrillation and myocardial infarction. Nature Reviews. Cardiology. 2023; 20: 631\u2013644.","DOI":"10.1038\/s41569-023-00857-3"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Zhang Q, Wu YX, Yu XQ, Zhang BY, Ma LY. EZH2 serves as a promising therapeutic target for fibrosis. Bioorganic Chemistry. 2023; 137: 106578.","DOI":"10.1016\/j.bioorg.2023.106578"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012; 492: 108\u2013112.","DOI":"10.1038\/nature11606"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Kaipananickal H, Waheed Khan A, Okabe J, Corcoran SJ, Esler MD, El-Osta A. Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome. Circulation Research. 2020; 126: 1058\u20131060.","DOI":"10.1161\/CIRCRESAHA.119.315654"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Colazzo F, Castiglioni L, Sironi L, Fontana L, Nobili E, Franzosi M, et al. Murine left atrium and left atrial appendage structure and function: echocardiographic and morphologic evaluation. PloS One. 2015; 10: e0125541.","DOI":"10.1371\/journal.pone.0125541"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Murakata Y, Yamagami F, Murakoshi N, Xu D, Song Z, Li S, et al. Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy. Frontiers in Cardiovascular Medicine. 2023; 9: 1075358.","DOI":"10.3389\/fcvm.2022.1075358"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Liu X, Zhang W, Luo J, Shi W, Zhang X, Li Z, et al. TRIM21 deficiency protects against atrial inflammation and remodeling post myocardial infarction by attenuating oxidative stress. Redox Biology. 2023; 62: 102679.","DOI":"10.1016\/j.redox.2023.102679"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Karakasis P, Theofilis P, Milaras N, Vlachakis PK, Patoulias D, Karamitsos T, et al. Epigenetic Drivers of Atrial Fibrillation: Mechanisms, Biomarkers, and Therapeutic Targets. International Journal of Molecular Sciences. 2025; 26: 5253.","DOI":"10.3390\/ijms26115253"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Donniacuo M, De Angelis A, Telesca M, Bellocchio G, Riemma MA, Paolisso P, et al. Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors. Pharmacological Research. 2023; 188: 106591.","DOI":"10.1016\/j.phrs.2022.106591"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Delgado-Olgu\u00edn P, Huang Y, Li X, Christodoulou D, Seidman CE, Seidman JG, et al. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nature Genetics. 2012; 44: 343\u2013347.","DOI":"10.1038\/ng.1068"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Kook H, Seo SB, Jain R. EZ Switch From EZH2 to EZH1: Histone Methylation Opens a Window of Cardiac Regeneration. Circulation Research. 2017; 121: 91\u201394.","DOI":"10.1161\/CIRCRESAHA.117.311351"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Wassef M, Luscan A, Aflaki S, Zielinski D, Jansen PWTC, Baymaz HI, et al. EZH1\/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019; 116: 6075\u20136080.","DOI":"10.1073\/pnas.1814634116"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Lin JM, Hsu CH, Chen JC, Kao SH, Lin YC. BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury. BioFactors. 2021; 47: 386\u2013402.","DOI":"10.1002\/biof.1704"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Peng Y, Zhao JL, Peng ZY, Xu WF, Yu GL. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death & Disease. 2020; 11: 317.","DOI":"10.1038\/s41419-020-2545-6"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Rondeaux J, Groussard D, Renet S, Tardif V, Dumesnil A, Chu A, et al. Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI. Nature Communications. 2023; 14: 4461.","DOI":"10.1038\/s41467-023-40186-0"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zhao L, You T, Lu Y, Lin S, Li F, Xu H. Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression. Journal of Molecular and Cellular Cardiology. 2021; 153: 95\u2013103.","DOI":"10.1016\/j.yjmcc.2020.12.012"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Seasock MJ, Shafiquzzaman M, Ruiz-Echartea ME, Kanchi RS, Tran BT, Simon LM, et al. Let-7 restrains an epigenetic circuit in AT2 cells to prevent fibrogenic intermediates in pulmonary fibrosis. Nature Communications. 2025; 16: 4353.","DOI":"10.1038\/s41467-025-59641-1"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Xia Q, Xu F, Zhang L, Ding W, Liu J, Liu J, et al. The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation. Molecular Biomedicine. 2025; 6: 36.","DOI":"10.1186\/s43556-025-00276-5"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Xia Y, Ye Z, Li B, Yan X, Yuan T, Li L, et al. EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis. Communications Biology. 2025; 8: 286.","DOI":"10.1038\/s42003-025-07735-3"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Li SS, Pan L, Zhang ZY, Zhou MD, Chen XF, Qian LL, et al. Diabetes Promotes Myocardial Fibrosis via AMPK\/EZH2\/PPAR-\u03b3 Signaling Pathway. Diabetes & Metabolism Journal. 2024; 48: 716\u2013729.","DOI":"10.4093\/dmj.2023.0031"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Karakasis P, Theofilis P, Vlachakis PK, Korantzopoulos P, Patoulias D, Antoniadis AP, et al. Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets. International Journal of Molecular Sciences. 2024; 26: 209.","DOI":"10.3390\/ijms26010209"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Sayers JR, Martinez-Navarro H, Sun X, de Villiers C, Sigal S, Weinberger M, et al. Cardiac conduction system regeneration prevents arrhythmias after myocardial infarction. Nature Cardiovascular Research. 2025; 4: 163\u2013179.","DOI":"10.1038\/s44161-024-00586-x"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/9\/10.31083\/RCM51343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:58:53Z","timestamp":1790693933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/9\/10.31083\/RCM51343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2153-8174(26)03635-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm51343","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"51343"}}